184 related articles for article (PubMed ID: 37231491)
1. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [
O'Connor A; Cash DM; Poole T; Markiewicz PJ; Fraser MR; Malone IB; Jiao J; Weston PSJ; Flores S; Hornbeck R; McDade E; Schöll M; Gordon BA; Bateman RJ; Benzinger TLS; Fox NC
Alzheimers Res Ther; 2023 May; 15(1):99. PubMed ID: 37231491
[TBL] [Abstract][Full Text] [Related]
2. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults.
McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176
[TBL] [Abstract][Full Text] [Related]
3. Partial volume correction in longitudinal tau PET studies: is it really needed?
Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
[TBL] [Abstract][Full Text] [Related]
4. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
5. Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study.
Xu G; Zheng S; Zhu Z; Yu X; Jiang J; Jiang J; Chu Z;
Ann Nucl Med; 2020 Nov; 34(11):815-823. PubMed ID: 32785820
[TBL] [Abstract][Full Text] [Related]
6. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.
Sanchez JS; Hanseeuw BJ; Lopera F; Sperling RA; Baena A; Bocanegra Y; Aguillon D; Guzmán-Vélez E; Pardilla-Delgado E; Ramirez-Gomez L; Vila-Castelar C; Martinez JE; Fox-Fuller JT; Ramos C; Ochoa-Escudero M; Alvarez S; Jacobs HIL; Schultz AP; Gatchel JR; Becker JA; Katz SR; Mayblyum DV; Price JC; Reiman EM; Johnson KA; Quiroz YT
Alzheimers Res Ther; 2021 Jan; 13(1):27. PubMed ID: 33451357
[TBL] [Abstract][Full Text] [Related]
8. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease.
Tian J; Raghavan S; Reid RI; Przybelski SA; Lesnick TG; Gebre RK; Graff-Radford J; Schwarz CG; Lowe VJ; Kantarci K; Knopman DS; Petersen RC; Jack CR; Vemuri P
Neurology; 2023 May; 100(22):e2269-e2278. PubMed ID: 37068958
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
10. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
12. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
[TBL] [Abstract][Full Text] [Related]
13. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.
Buckley RF; Scott MR; Jacobs HIL; Schultz AP; Properzi MJ; Amariglio RE; Hohman TJ; Mayblyum DV; Rubinstein ZB; Manning L; Hanseeuw BJ; Mormino EC; Rentz DM; Johnson KA; Sperling RA
Ann Neurol; 2020 Nov; 88(5):921-932. PubMed ID: 32799367
[TBL] [Abstract][Full Text] [Related]
14. Tau-positron emission tomography correlates with neuropathology findings.
Lowe VJ; Lundt ES; Albertson SM; Min HK; Fang P; Przybelski SA; Senjem ML; Schwarz CG; Kantarci K; Boeve B; Jones DT; Reichard RR; Tranovich JF; Hanna Al-Shaikh FS; Knopman DS; Jack CR; Dickson DW; Petersen RC; Murray ME
Alzheimers Dement; 2020 Mar; 16(3):561-571. PubMed ID: 31784374
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
Mundada NS; Rojas JC; Vandevrede L; Thijssen EH; Iaccarino L; Okoye OC; Shankar R; Soleimani-Meigooni DN; Lago AL; Miller BL; Teunissen CE; Heuer H; Rosen HJ; Dage JL; Jagust WJ; Rabinovici GD; Boxer AL; La Joie R
Alzheimers Res Ther; 2023 Sep; 15(1):157. PubMed ID: 37740209
[TBL] [Abstract][Full Text] [Related]
16. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.
Wisch JK; McKay NS; Boerwinkle AH; Kennedy J; Flores S; Handen BL; Christian BT; Head E; Mapstone M; Rafii MS; O'Bryant SE; Price JC; Laymon CM; Krinsky-McHale SJ; Lai F; Rosas HD; Hartley SL; Zaman S; Lott IT; Tudorascu D; Zammit M; Brickman AM; Lee JH; Bird TD; Cohen A; Chrem P; Daniels A; Chhatwal JP; Cruchaga C; Ibanez L; Jucker M; Karch CM; Day GS; Lee JH; Levin J; Llibre-Guerra J; Li Y; Lopera F; Roh JH; Ringman JM; Supnet-Bell C; van Dyck CH; Xiong C; Wang G; Morris JC; McDade E; Bateman RJ; Benzinger TLS; Gordon BA; Ances BM; ;
Lancet Neurol; 2024 May; 23(5):500-510. PubMed ID: 38631766
[TBL] [Abstract][Full Text] [Related]
18. [
Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H
Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823
[TBL] [Abstract][Full Text] [Related]
19. Reduced [
Moscoso A; Grothe MJ; Schöll M;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
[TBL] [Abstract][Full Text] [Related]
20. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
